Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5370_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
20 Мб
Скачать
148 Surface Modication of Magnesium and its Alloys for Biomedical Applications
The aim of histological preparation is to visualise reactions in tissue using an appropriate stain. Use of different staining agents and suitable means of staining cre­ates high-contrast images that allow structural analysis. A basic distinction can be made between progressive and regressive techniques. It is assumed that the different structures retai n the stain to differing extents (Lang, 2006). Other options are those of indirect and direct staining and single or multiple staining (Lang, 2006). In histolog­ical examinations it is crucial that, following explantation of the sample, the mate­rials, methods, and analysis used are comparable with other test materials, sites, and research teams. A selection of staining agents and techniques are described below.
4.5.3.1 Haematoxylin staining
The direct staining agent is haematein or oxidised haematoxylin (Romeis, 1989). The haematoxylin stain is yellow brown in colour and is suited for progressive or regressive staining of cell nuclei (Lang, 2006). Subsequent rinsing in water gives it its typical pur­ple colour. Addition of eosin stains alkaline structures, such as cytoplasmic proteins, red.
4.5.3.2 Toluidine blue
This stain dyes cell nuclei a distinct blue colour and is suitable for making metachro­masy visible (Schauer & Scheibe, 1959), a property that allows structures such as mast cell granules and cartilage matrix to be stained purple. Toluidine blue provides a good overall view and is particularly well suited for visualising bone tissue. Cells, cell nuclei, osteoid seam, osteoclasts, and osteoblasts are stained different shades of blue. Mineralised tissue appears pale blue.
4.5.3.3 Van Giesons stain
This is a triple stain suitable for viewing connective tissue. Cell nuclei appear blue­black; collagen, bright red; calcied bone, red; osteoid, muscle tissue, and cytoplasm, yellow; and mast cell granules, red-brown. Amyloid, hyaline, and mucus are visible in various tones between yellow and red (Romeis, 1989).
4.5.3.4 Masson-Trichrome-Goldner stain
Using this multiple stain, cells of mineralised and nonmineralised bone matrix show up well. This property makes it the stain of choice for examining the morphology of non­calcied bone. The cell nuclei appear brownish black, and cytoplasmic staining makes it possible to distinguish between osteoclasts and osteoblasts (Lang, 2006; Romeis,
1989; Schwarz et al., 2007).
4.5.3.5 Tartrate-resistant acid phosphatase
One of the group of enzymatic histological stains, this allows reliable detection of osteoclasts,which appear a reddish-pink colour, and osteoclast progenitor cells (Ballanti et al., 1997). It has been observed that, under certain conditions, other cells,
Bioabsorbable behaviour of magnesium alloys e an in vivo approach 149
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
such as osteoblasts and osteocytes, may also be stained (Bianco et al., 1988; Nakano,
Toyosawa, & Takano, 2004).
4.3.5.6 Movats pentachrome stain
This is a multiple stain suitable for visualising different tissue types. Connective tissue appears red; mineralised bone tissue, yellow ; mineralised cartilaginous tissue, blue-green; and nonmineralised cartilaginous tissue, reddish-yellow. Collagen fi- bres stain yellow; osteoid, dark red; cell nuclei, blue-black; and cytoplasm, a red­dish colour.
4.5.4 Fluorescent microscopy
Another method of examining histological sections is uore scen ce microscopy. Monochromeor polychrome in vivo uorescence labelling with urochromes allows the assessment of remodelling processes and the quanticationofbonegrowthover time (Rahn, Bacellar, Trapp, & Perren, 1980; W itte et al., 2005). Rahn et al. (1980) developed dosage regimens for animals and polychrom e labelling using ve different-coloured staining agents: xylenol orange, calcein green, tetracycline, aliz­arin complex, and calcein blue. These substances are generally applied subcutane­ously or intravenously in an aqueous medium. The intravital staining dyes have frequently been used in vivo in recent years; the only such stain to be used in humans was tetracycline (An, 2003; Iwamoto, Takeda, Sato, & Yeh, 2004; Xu
et al. 2009).
4.5.5 Scanning electron microscopy and energy-dispersive X-ray spectroscopy
Scanning electron microscopy (SEM) is suitable for ultrastructural assessment be­tween implant and tissue (An, 2003). (See Section 4.4.4 on biodegeneration.)
4.5.6 Micro-computed tomography and histomorphometry
Micro-CT allows both two- and three-dimensional visualisation of bone and provides clear views of bone structure (Bernhardt et al., 2004). The two-dimensional images can also be used to obtain morphometric parameters (Partt, 1988). Histomorphom­etry makes it possible to assess structural changes in the surrounding tissue and the implantetissue interface (An, 2003). As well as providing options for quantit ative analysis, this method has a further advantage, namely that the specimen is available for further mechanical and histological investigations and large quantities can be examined (Ruegsegger, K oller, & Mueller, 1996; Wachter et al., 2001). In recent years, this time-consuming evaluation has been simplied by computer programs (Huffer, Ruegg, Zhu, & Lepoff, 1994; Martin et al., 2002). To correctly evaluate the histomorphometric ndings, it is necessary t o apply the same scann in g parame­ters, but not the standardised sectional planes with the same threshold level
150 Surface Modication of Magnesium and its Alloys for Biomedical Applications
(Ruegsegger et al., 1996). Analysis is carried out using quantit ative and semiquanti­tative point systems. Partt (1988) standardised the nomenclature and unied the ter­minology (see Table 4.6). Analysis includes the measurement of bone mass (expressed as a percentage), bone volume/total volume (Smet et al., 2006), trabecular thickness, and trabecular number (Gabetetal.,2006). Wachter et al. (2001) postulate that histomorphometry is, in terms of bone assessment, superior to histological exam­ination. Admittedly, one disadvantage is the lack of information on the biological characteristics of bone, particularly the evaluation of periosteal and endosteal remod­elling. However, studies by a number of research teams show that the outcome of micro-CT analysis closely matches that of histological ndings (Butz, Ogawa,
Chang, & Nishimura, 2006; Stopie et al., 2007; van Oosterwyck et al., 2000)(see Figure 4.15).
4.5.7 Chemical analysis (blood, other specimens)
Especially with biodegradable materials, the question arises as to whether degradation products inuence not only the implantetissue interface but also directly or indirectly affect (or are stored in) other organs. One current means of evaluating this is to test the blood of animal subjects for magnesium. Another option is to examine the regional lymph nodes or the kidney s, the organs of elimination. Several authors report un­changed magnesium serum concentration (Li et al., 2008; Wong et al., 2010; Xu
et al., 2007) or changes in organ function (Witte et al., 2010; Zhang et al., 2010,
2009) (see Table 4.7).
4.6 Testing of magnesium alloy in or on bone e special considerations
This section begins with a discussion of the advantages and disadvantages of implant materials currently used in the vicinity of bone marrow, intended to highlight the sig­nicance of magnesium for the manufacture of implants to be used in bone.
4.6.1 Metallic nonresorbable implants
Osteosynthesis materials generally used at present include high-allo yed stainless steel, pure titanium, and titanium alloys (Disegi, 2000; Jain, Podworny, Hearn, Ande rson, &
Schemitsch, 1997; Pohler, 2000; Singh & Dahotre, 2007). Less expensive than tita-
nium, high-alloyed stainless steel is characterised not only by a high degree of mechan­ical strength and hardness, but also by good corrosion resistance (Disegi & Eschbach,
2000; Singh & Dahotre, 2007). Owing to their high density (almost double that of ti-
tanium), steel implants are substantially heavier thanand have considerably greater elasticity thantitanium, which in turn is more elastic than the cortex of the bone (Dis-
egi & Eschbach, 2000; Pohler, 2000). Biocompatibility is affected by metal ions such
as nickel, chromium, and cobalt, which are released during the corrosion process
Bioabsorbable behaviour of magnesium alloys e an in vivo approach 151
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 4.6 Comparison of new with old terminology for selected
primary measurements (upper list) and derived indices (lower list) on cancellous bone tissue; methods of calculating the latter are given in original
Present terminology
Trabecular
d
a
bone
Proposed terminology
Bone volume
b,c
e
Abbreviation Units
e
BV/TV
volume (TBV)
(Relative) osteoid
Osteoid volume OV/BV %
volume (ROV)
(Absolute) osteoid
volume
f
(AOV)
(Relative) osteoid
Osteoid volume OV/TV %
Osteoid surface OS/BS %
surface (ROS)
g
(Active
) osteoblast
Osteoblast surface Ob.S/BS
surface (AOS)
i
(Mean
) osteoid seam
Osteoid thickness O.Th mcm
width (MOSW)
(Total) resorption
(Active
surface
j
(TRS)
k
) resorption
Eroded surface ES/BS %
Osteoclast surface Oc.S/BS
surface (ARS)
Osteoclast index (OI) Osteoclast number N.Oc/T.Ar
(Trabecular) specic
surface
n
(tSsp)
(Meani) wall
Bone surface BS/TV mm
Wall thickness W.Th. mcm
thickness (MWT)
o
surface
forming
p
(AFS)
Active
Mineralisation
(MF)
Calcication
(CR)
i
trabecular
Mean
plate thickness
r
q
rate
front
Mineralising
Mineralising
Mineral apposition
s
Trabecular
MS/BS %
surface
MS/OS %
surface
MAR mcm/d
rate
Tb.Th mcm
thickness
(MTPT)
%
h
l
m
%
%
/mm
2
2
/mm
3
Continued
152 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Table 4.6 Comparison of new with old terminology for selected
primary measurements (upper list) and derived indices (lower list) on cancellous bone tissue; methods of calculating the latter are given in original e contd
Present terminology
i
Mean
trabecular
a
Proposed terminology
s
Trabecular number
b,c
Abbreviation Units
t
Tb.N /mm plate density (MTPD)
i
trabecular
Mean
plate separation
s
Trabecular
separation
t
Tb.Sp mcm
(MTPS)
Bone formation rate,
BMU level (sV
Bone formation rate,
tissue level (
Bone formation rate,
volume referent
(BMU
u
)
S
Vf)
v
Adjusted apposition
rate
Bone formation rate BFR/BS mcm
Bone formation rate BFR/BV %/year
Aj.AR mcm/d
3
/mcm2/year
(vVf)
Mineralisation lag
time (MLT)
Sigma (duration of
Mineralisation lag
Mlt day
time
Formation period FP Day or year
formation) (of)
a
These are representative of current practice in different laboratories; it is not implied that all are used by any laboratory or
that any are used by most laboratories. Qualifying terms are in parentheses if their use is inconsistent between laboratories.
b
Measurement name only; need for inclusion of source and/or referent in name varies with context, as discussed in original.
c
Three-dimensional expression except where otherwise stated.
d
Source almost always included in name for this quantity, often omitted for others.
e
The full name and abbreviation would be cancellous bone volume/tissue volume (Cn-BV/TV); see notes b and d.
f
Also called osteoid volume density.
g
Designation usually based on morphology.
h
OS is another frequently used referent.
i
Including meanas part of the name should imply direct rather than indirect measurement and may lead to confusion with
the mean value in a group of subjects.
j
Also termed crenated or Howships lacunar surface.
k
Designation usually based on presence of osteoclasts.
l
ES sometimes used as an additional referent.
m
Bone perimeter is an alternative referent; note that expression must be 2D, not 3D.
n
Also called surface density.
o
Note wide variety of meanings presently given to the term active.
p
Often called labeled surfaceor tetracycline surface(double, single, or both).
q
Or calci cation.
r
Or mineralisation.
s
Note ambiguity between trabecularas a type of bone tissue and as a type of individual structural element.
t
Must specify whether calculated according to parallel plate or rod model or measured directly.
u
Many other synonyms given in original.
v
Equivalent to rate of bone turnover.
Partt (1988).
Bioabsorbable behaviour of magnesium alloys e an in vivo approach 153
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Figure 4.15 The histological sections (1) and their corresponding micro-CT images (2) for a titanium implant placed in the trabecular bone of the condyle of the left tibia of the rabbit. The left side of the implant corresponds to the ventral side of the tibia and the right side of the implant to the dorsal side of thetibia (Stopie et al., 2007).
Table 4.7 Blood biochemical examination of rat before implantation
and 15 weeks post-implantation of MgeMneZn alloy in a bone
Before implantation
Items
(n [ 2)
BUN (mmol/L) 7.07 0.32 8.47 0.51 5.99e14.99
CREA (mmol/L) 35.6 3.1 39.0 3.1 29.2e53.9
UA (mmol/L) 35 950 10 71.3e445.5
Kþ(mmol/L) 6.20 0.99 6.40 1.0 3.8e5.4
þ
Na
(mmol/L) 141.5 0.7 145.0 1.4 126e155
Cl
(mmol/L) 100.0 4.2 101.5 2.1 103.0e115.1
2þ
Ca
(mmol/L) 2.95 0.04 2.93 0.07 3.1e5.2
P (mmol/L) 2.93 0.08 2.99 0.42 1.0e3.55
2þ
Mg
(mmol/L) 1.18 0.05 1.28 0.13 1.32 0.03
Xu et al. (2007).
15 Weeks post­implantation
(n ¼ 2)
Recommended
13
level
14
14
14
154 Surface Modication of Magnesium and its Alloys for Biomedical Applications
(Hallab, Jacobs, & Black, 2000; Singh & Dahotre, 2007; Ungethuem & Winkler-
Gniewek, 1984), potentially resulting in allergies and in septic and aseptic reactions
(Singh & Dahotre, 2007). Titanium and its alloys exhibit excellent biocompatibility and corrosion resistance, as well as favourable mechanical properties (Singh &
Dahotre, 2007) (see Table 4.8). Their only notable disadvantages are that their elastic-
ity is higher than that of bone and both their wear resistance and their resistance to shearing forces is lower (Singh & Dahotre, 2007). Due to their high-elasticity module, the above-mentioned metallic implants show substantially higher rigidity than bone, leading to stress shielding and, in turn, to a delay in the healing process, to
Table 4.8 Characteristics of strategic orthopaedic metallic materials
Ti and Ti-base
Characteristics Stainless steels Cobalt-base alloys
alloys
Designation ASTM F-138 (316
LDVMO)
Principal alloying
elements (wt. %)
Advantages Cost, availability,
Disadvantages Long-term
Application Temporary devices
Fe (balance)
Cr (17e20) Ni (10e14) Mo (2e4)
processing
behaviour, high modulus
(fracture plates, screws, hip nails) used for THRs stems
ASTM F-75 ASTM
F-799 ASTM F-1537 (cast and wrought)
Co (balance)
Cr (19e30) Mo (0e10) Ni (0e37)
Wear resistance,
corrosion resistance, fatigue strength
High modulus Low wear
Dentistry casting,
prostheses stems load-bearing components in TJR (wrought alloys)
ASTM F-67 (ISO
5832/II) ASTM F-136 (ISO 5832/II) ASTM F-1295 (cast and wrought)
Ti (balance) A1 (6)
V (4) Nb (7)
Biocompatibility
corrosion resistance minimum modulus fatigue strength
resistance, low shear resistance
In THRs (with
modular Co-Cr­Mo or ceramic) femoral heads, long-term permanent devices (nails, pacemakers)
Singh and Dahotre (2007).
Bioabsorbable behaviour of magnesium alloys e an in vivo approach 155
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
development of pseudoarthrosis and to pathological fractures following implant removal (Gogolewski, 2000; Hoffmann, 1995).
Tissue metallosis around the implant was found to be another drawback of nonre­sorbable metallic implants, potentially leading to hypersensitivity, toxicity, and can­cerogenicity (Agins et al., 1988; Mcdonald, Enneking, & Sundaram, 2002; Radhi,
Ibrahiem, & Al-Tweigeri, 1998; Ward, Thornbury, Lemons, & Dunham, 1990). The
generation of artefacts in CT (Link et al., 2000; Mahnken et al., 2003) and magnetic resonance imaging (MRI) (Disegi & Eschbach, 2000; Pohler, 2000) is also disadvantageous.
4.6.2 Resorbable polymer-based implants
PGAs, PLAs, and their copolymers are among the main substances used for manufacturing osteosynthesis materials (Claes & Ignatius, 1998). Their elasticity model resembles bone properties and thus prevents stress protection (Hofmann,
1995). However, rapid loss of strength and rigidity irrespective of the degradation pro-
cess presents a problem (Hofmann, 1995). This means that the implants are suitable only for the treatment of non-load-bearing bones (Hofmann, 1995; Rehm et al.,
1997; von der Elst et al., 2000). Chemical composition, crystallinity, release of degra-
dation products, implant design, and surface properties are major determinants of biocompatibility (Gogolewski, 2000; Hoffmann, Weller, Helling, Kre ttek, & Rehm,
1997; Wintermantel, 2002) (see Table 4.9). Several research teams investigating
biocompatibility regard foreign-body reactions as having negative effects ranging from silent osteolysis to severe inammation (B€ostman, 1991, 1992; Claes & Ignatius,
1998; Hoffmann et al., 1997; Suganuma and Alexander, 1993; Rehm, Helling, & Claes, 1994). Another disadvantage is that the implants cannot be imaged using CT
and MRI (Hofmann, 1995; Rehm et al., 1997).
4.6.3 Suitability of magnesium and its alloys for metallic
implants
Magnesium and its alloys have an elasticity module that resembles that of the cortex of the bone and generally possess similar mechanical properties (Kaese, 2002; Staiger
et al., 2006; Zhang et al., 2009). A large number of in vitro and in vivo studies postulate
that magnesium ions, magnesium, and degradation products (i.e., magnesium hydrox­ide) have a positive inuence on the bone-remodelling processes and an osteoconduc­tiveeffect (Castellani et al., 2011; Janning et al., 2010; Pietak, Mahoney, Dias, &
Staiger, 2008; Revell, Damien, Zhang, Evans, & Howlett, 2004; Rude et al., 2006; Witte et al., 2005; Witte et al., 2007; Yamasaki et al., 2002; Yamasaki et al., 2003; Zreiqat et al., 2002) (see Table 4.10 and Figure 4 .16). It has been shown that calcium
phosphate coating of implants has a positive effect on bone healing and thus ensures better implant integration (Hayakawa, Yoshinari, Nemoto, Wolke, & Jansen, 2000). The increase in pH value during degradation may also lead to osteoblast stimulation (Kaese, 2002). As soon as the capacity for resorption of the surrounding tissue has been exceeded, gas bubbles form (Witte, Hort, et al., 2008). These are resorbed
156 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Table 4.9 Degradation rates of various resorbable polymeric implants
Complete Polymer (implant form)
Retained strength (%/week)
Total strength loss (months)
resorption time
(months)
Polydioxanone
(sutures)
Poly(glycolide-
co-trimethylene carbonate) (sutures)
Polyglycolide
(sutures)
PoIy(glycolide-co-
lactide)(sutures)
Poly(
L-lactide)
(solid, non­oriented)
L-lactide)
Poly(
(solid, oriented)
Poly(L/DL-lactide)
70/30% (solid, nonoriented)
Poly(L/DL-lactide)
80/20% (solid, nonoriented)
Poly (L/DL-lactide)
80/20% (porous membranes)
60/4 (40/6) 26
55/4 (14/7) 2.5 6
30/2 1 4
30/3 1 2
40/8 3 1e72
80/12 (65/25) 1e736e72
a
40/12
50/12
20/12
a
a
324e36
424e36
412e18
a
a
a
a
Values to be proven by further experiments.
Gogolewski (2000).
over a period of several weeks; no negative effect on the surrounding tissue could be demonstrated (Erdmann et al., 2011; Hampp et al., 2012; Kraus et al., 2012; Li et al.,
2008; Witte et al., 2005; Zhang, Xu, et al., 2009). Several research teams suggest that
compact implantation material may hinder the closure of a borehole in the cortex by preventing an inux of osteoprogenitor cells (Henslee et al., 2011). The rabbit animal model is favoured and recommended for in vivo studies (Meyer-Lindenberg et al.,
2007; Tsai et al., 2008; Carranza-Bencano et al., 1999; Rudert, 2002; ISO 10993-6:
2007).
It is essential that bone implants are sufciently stable, especially during the
rst few weeks. Based on the assumption t hat fractures of the thigh take around
Bioabsorbable behaviour of magnesium alloys e an in vivo approach 157
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 4.10 Maximum push-out force (F
) and energy absorption to failure (EA) for each implantation
(s
u
), ultimate shear strength
max
period and implant type (median [rst to third quartiles], ManneWhitney U-test)
Implantation period Mg-alloy Ti-alloy P
4 weeks n 12 13
F
(N) 49.35 (37.63e55.53) 23.58
max
(N/
s
u
mm
2.43 (1.80e2.81) 1.12 (0.57e1.50) 0.002
2
)
EA (mJ) 1.07 (0.92e1.40) 0.39 (0.17e0.79) 0.004
12 weeks n 12 7
(n) 151.87
f
max
(133.30e185.33)
(N/
s
u
mm
6.17 (5.29e7.23) 4.14 (3.25e4.55) 0.002
2
)
EA (mJ) 12.45 (9.08e18.70) 3.24 (2.23e7.41) 0.002
24 weeks n 89
(N) 185.16
F
max
(157.73e221.9S)
(N/
s
u
mm
7.65 (6.61e8.71) 2.14 (1.26e3.53) 0.001
2
)
EA (mJ) 22.64 (11.05e36.86) 0.70 (0.36e1.46) 0.004
(11.55e30.99)
100.83 (80.10e109.59)
44.78 (30.57e90.10)
0.001
0.003
0.001
Castellani et al. (2011).
12 weeks to heal (Gu et al., 2011), Staiger et al. (2006) advocate that biodegradable implants should have sufcient mechanical properties for at least this length of time. Hutmacher (2000) recommends that osteosynthesis materials used in bone should have biomechanical stability of around 2 months prior to the expected onset of controlled degradation. The degeneration rate of magnesium implants differs depending on their location in the bone; it is greater in the medullary cavity than in the cortical bone (Erdmann et al., 2011; Xu et al., 2007; Zhang, Xu, et al.,
2009)(seealsoSection 4.2). In a study by Xu et al. (2007), the magnesium alloy
in rat femurs degraded by 10e17% over the rst 9 weeks, with only 50% of t he original amount remaining after a total of 18 weeks. However, in the treatment of iatrogenic bone/cartilage defects with magnesium sponges made of the AZ91 alloy, the formation of degradation products prevented the onset of the h oped -for